Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Silk Biomaterials S R L currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. Examiner BORGEEST, CHRISTINA M is responsible for this matter within a single art unit.
The portfolio involves 1 distinct examiner and a distinct art unit. BORGEEST, CHRISTINA M serves as the busiest examiner for the company, holding 1 pending office action. This centralized prosecution requires the applicant to align their strategy with the specific tendencies of the assigned examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BORGEEST, CHRISTINA M | 1 | 55.7% | +21.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681534 | BIOMIMETIC PEPTIDES AND THEIR USE IN BONE REGENERATION | BORGEEST, CHRISTINA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681534 | BIOMIMETIC PEPTIDES AND THEIR USE IN BONE REGENERATION | BORGEEST, CHRISTINA M | — |
| Art Unit | Apps |
|---|---|
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18681534 | BIOMIMETIC PEPTIDES AND THEIR USE IN BONE REGENERATION | BORGEEST, CHRISTINA M | 1675 | §101§112 | Non-Final OA | — | Pending | Feb 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSilk Biomaterials S R L has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Christina M Borgeest has the most, with 1 of Silk Biomaterials S R L's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
